Biopharm Services Limited
Private Limited Company · Beaconsfield
ActiveUnited KingdomIncorporated 1998Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-12-31
IXBRL · 135 source facts · 10 selected values
Validation findingsXBRL valid
Accounts to 2025-12-31
IXBRL · 135 source facts · 10 selected values
Validation findings
XBRL valid
- Reporting period
- 2025-01-01 to 2025-12-31
- Extraction status
- complete
- Numeric facts
- 95
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2608_03656605_20251231
- Source archive
- Accounts_Monthly_Data-August2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-12-31
IXBRL · 151 source facts · 10 selected values
Validation findingsXBRL valid
Accounts to 2024-12-31
IXBRL · 151 source facts · 10 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- complete
- Numeric facts
- 111
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2508_03656605_20241231
- Source archive
- Accounts_Monthly_Data-August2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-12-31
IXBRL · 156 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 156 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 101
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2266_03656605_20231231
- Source archive
- Accounts_Monthly_Data-June2024.zip
Accounts to 2022-12-31
IXBRL · 138 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2022-12-31
IXBRL · 138 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2022-01-01 to 2022-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 89
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0014_03656605_20221231
- Source archive
- Accounts_Monthly_Data-May2023.zip
Accounts to 2021-12-31
IXBRL · 142 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2021-12-31
IXBRL · 142 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2021-01-01 to 2021-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 85
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0106_03656605_20211231
- Source archive
- Accounts_Monthly_Data-May2022.zip
Accounts to 2020-12-31
IXBRL · 119 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2020-12-31
IXBRL · 119 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-01 to 2020-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 64
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0091_03656605_20201231
- Source archive
- Accounts_Monthly_Data-June2021.zip
Accounts to 2019-12-31
IXBRL · 109 source facts · 14 selected values
Not assessedlegacy record
Accounts to 2019-12-31
IXBRL · 109 source facts · 14 selected values
Not assessed
legacy record
- Reporting period
- 2019-01-01 to 2019-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 54
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0077_03656605_20191231
- Source archive
- Accounts_Monthly_Data-April2020.zip
Registered details
03656605- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 1998-10-27
- Jurisdiction
- —
- Registered office
- 22, WYCOMBE END, BEACONSFIELD, BUCKINGHAMSHIRE, HP9 1NB
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
7 matched grantsIntegrating Continuous Technologies Rapid Delivery of Cost Effective Biotherapeutics to PatientsLeadInnovate UK · Collaborative R&D · 2021-05-01 – 2024-01-31 · with 4 other participants£213,282awarded
Integrating Continuous Technologies Rapid Delivery of Cost Effective Biotherapeutics to PatientsLead
Innovate UK · Collaborative R&D · 2021-05-01 – 2024-01-31 · with 4 other participants
£213,282
awarded
Biopharm Services Limitedlead£213,282
The University of Manchester and Biopharm Services LimitedInnovate UK · Knowledge Transfer Partnership · 2017-08-01 – 2020-04-30 · with 1 other participant
The University of Manchester and Biopharm Services Limited
Innovate UK · Knowledge Transfer Partnership · 2017-08-01 – 2020-04-30 · with 1 other participant
Biopharm Services Limited—
Future Targeted Healthcare Manufacturing HubEPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 90 other participants£10,851,089whole project
Future Targeted Healthcare Manufacturing Hub
EPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 90 other participants
£10,851,089
whole project
University College Londonlead3MAdaptimmuneAglaris LtdAlbumedix LtdAlbumedix LtdAllerganAllergan Limited (UK)Applikon Biotechnology B.V.Association of the British Pharmaceutical IndustryAssoc of the British Pharm Ind (ABPI)AstrazenecaAstraZenecaAutolusAutolus LimitedAutolus LtdBIA SeparationsBioindustry AssociationBioLogicB LLCBioLogicB, LLCBiopharm ServicesBiopharm Services LimitedCancer Research UKCell And Gene Therapy CatapultCell Medica Ltd.Celltech Group plcCell Therapy CatapultCentre for Process InnovationCentre for Process Innovation (CPI)CSL BehringdeltaDOT LtdEli Lilly & Company LtdEli Lilly S.A. - Irish BranchFloDesign SonicsFrancis BiopharmaFrancis Biopharma LtdFujifilmFujifilm UK LtdGlaxoSmithKline (GSK)GskImperial College LondonIpsenIrvine ScientificKnowledge Transfer NetworkKnowledge Transfer Network LimitedKuopio Center for Gene and Cell TherapyLaboratory of the Government Chemist (LGC) LtdLgcLgc LtdLonza Biologics PLCLonza GroupMedicines & Healthcare pdts Reg Acy MHRAMedicines Manufacturing Ind PartnershipMedicines Manufacturing Industry PartnershipMerck KGaAMerck Sharpe and DohmeNational Institute for Biological Standards and Control (NIBSC)Novo Nordisk A/SOrchard TherapeuticsOvizio Imaging Systems NV SAOxford BioMedica UK LtdOxford BioMedica (United Kingdom)Pall EuropePerceptive Engineering LimitedPerceptive Engineering LtdPfizerPharmaronPuridifyPuridify LTDPurolite International LtdRedbud LabsReneuronReneuron LtdRepligenRoche Diagnostics GmbHSartoriusSartorius Stedim UK LimitedShanghai Pulmonary HospitalSsc BioSutro BiopharmaTillingbourne Consulting LimitedTrakCelUcb SAUK BioIndustry Association (BIA)United Kingdom Research and InnovationUnivercells LtdUniversity College LondonUniversity of WarwickWest Pharmaceutical ServicesWyatt Technology CorporationWyatt Technology UK Ltd
Bioprocess Database Application to Support Rapid Bioprocess Development and Technology Transfer to ManufacturingLead
Innovate UK · GRD Proof of Concept · 2012-02-01 – 2012-12-31
£60,000
awarded
EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular TherapiesEPSRC · Research Grant · 2011-09-30 – 2016-12-31 · with 48 other participants£5,840,286whole project
EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies
EPSRC · Research Grant · 2011-09-30 – 2016-12-31 · with 48 other participants
£5,840,286
whole project
University College LondonleadAegis AnalyticalAegis Analytical CorpAssociation of the British Pharmaceutical IndustryAstrazenecaAstraZenecaAvacta GroupAvacta Group PLCBioindustry AssociationBiopharm ServicesBiopharm Services LimitedBtgBtg PLC (UK)Celltech Group plcEDEN BiodesignEli Lilly & Company LtdEli Lilly S.A. - Irish BranchFrancis BiopharmaFrancis Biopharma LtdFujifilmGE HealthcareGE Healthcare LimitedGskHealth Protection AgencyHealthTech and Medicines Knowledge Transfer Network (Health KTN)Innovate UKLgc LtdLonza Biologics PLCLonza GroupMedicines & Healthcare pdts Reg Acy MHRAMerckMerck Sharpe and DohmeMSD Biologics UK LtdNational Institute for Biological Standards and Control (NIBSC)NHS EnglandNovo NordiskNovo Nordisk A/SNovozymes Biopharma UK LtdOffice of Health Economics (OHE)Pall EuropePfizerPfizer IncPolythericsPublic Health EnglandSyntaxin LtdTAP BiosystemsThe Association of the British Pharm IndUcb SAUK BioIndustry Association (BIA)
IMRC for BioprocessingEPSRC · Research Grant · 2007-03-31 – 2012-03-30 · with 28 other participants£5,913,161whole project
IMRC for Bioprocessing
EPSRC · Research Grant · 2007-03-31 – 2012-03-30 · with 28 other participants
£5,913,161
whole project
University College LondonleadAstraZenecaAvecia LimitedBIA SeperationsBiopharm Services LimitedBio Products LaboratoryBiovex LtdCelltech Group plcEli Lilly and Company (International)Eli Lilly (United Kingdom)GE (General Electric Company)GE (General Electric Company) UKGskIntercell Biomedical LtdLonza Biologics PLCMedicines & Healthcare pdts Reg Acy MHRAMerck Sharpe and DohmeNovasep SASNovo Nordisk A/SPall EuropePfizerPfizer Global R and DPrometic Biosciences LtdProtherics PlcProtherics UK LimtedPublic Health EnglandSt George'S University Of LondonTAP BiosystemsWyeth USA
Novel Technologies Underpinning Bioprocessing Development and ManufacturingLeadInnovate UK · Collaborative R&D · 2006-05-01 – 2010-01-31 · with 2 other participants£317,891awarded
Novel Technologies Underpinning Bioprocessing Development and ManufacturingLead
Innovate UK · Collaborative R&D · 2006-05-01 – 2010-01-31 · with 2 other participants
£317,891
awarded